Identification of the RT-RH/IN cleavage site of HTLV-I
- PMID: 12504078
- DOI: 10.1016/s0006-291x(02)02848-6
Identification of the RT-RH/IN cleavage site of HTLV-I
Abstract
Human T-cell leukemia virus type 1 (HTLV-1) is a type C human retrovirus and is the causative agent of adult T-cell leukemia and other diseases. The enzymatic and structural proteins of HTLV-I are synthesized as part of a Gag-Pro-Pol precursor polyprotein, and the mature proteins are released by proteolytic processing catalyzed by HTLV-I protease. The locations of most of the proteolytic cleavage sites are known, however, the site that creates the N-terminus of HTLV-1 integrase has not been previously identified. A 15 residue peptide corresponding to junction of the C-terminus of RNaseH and N-terminus of integrase (DALLITPVLQLSPAF-OH) was incubated with HTLV-1 protease. Analysis of the cleavage products by LC-MS revealed fragments Ac-DALLITPVLQL-OH and H(2)N-SPAF-OH were produced, indicating cleavage between the leucine and serine. This is the first physical identification of the N-terminal amino acid sequence of the integrase of HTLV-1.
Similar articles
-
Proteolytic processing of the human T-cell lymphotropic virus 1 reverse transcriptase: identification of the N-terminal cleavage site by mass spectrometry.Arch Biochem Biophys. 2001 Aug 1;392(1):93-102. doi: 10.1006/abbi.2001.2432. Arch Biochem Biophys. 2001. PMID: 11469799
-
Human T-cell leukemia virus type 1 reverse transcriptase (RT) originates from the pro and pol open reading frames and requires the presence of RT-RNase H (RH) and RT-RH-integrase proteins for its activity.J Virol. 1998 Aug;72(8):6504-10. doi: 10.1128/JVI.72.8.6504-6510.1998. J Virol. 1998. PMID: 9658093 Free PMC article.
-
Synthesis, processing, and composition of the virion-associated HTLV-1 reverse transcriptase.J Biol Chem. 2006 Feb 17;281(7):3964-71. doi: 10.1074/jbc.M507660200. Epub 2005 Dec 19. J Biol Chem. 2006. PMID: 16368688
-
The protease of human T-cell leukemia virus type-1 is a potential therapeutic target.Curr Pharm Des. 2007;13(12):1285-94. doi: 10.2174/138161207780618849. Curr Pharm Des. 2007. PMID: 17504236 Review.
-
Understanding HTLV-I protease.Chem Biol. 2003 May;10(5):373-80. doi: 10.1016/s1074-5521(03)00104-2. Chem Biol. 2003. PMID: 12770819 Review. No abstract available.
Cited by
-
The N-end rule and retroviral infection: no effect on integrase.Virol J. 2013 Jul 13;10:233. doi: 10.1186/1743-422X-10-233. Virol J. 2013. PMID: 23849394 Free PMC article.
-
Delayed seroconversion to STLV-1 infection is associated with mutations in the pol and rex genes.Virol J. 2013 Sep 11;10:282. doi: 10.1186/1743-422X-10-282. Virol J. 2013. PMID: 24025129 Free PMC article.
-
Development of a cytotoxic T-cell assay in rabbits to evaluate early immune response to human T-lymphotropic virus type 1 infection.Viral Immunol. 2009 Dec;22(6):397-405. doi: 10.1089/vim.2009.0059. Viral Immunol. 2009. PMID: 19951176 Free PMC article.
-
T-cell control by human T-cell leukemia/lymphoma virus type 1.Int J Hematol. 2003 Nov;78(4):280-96. doi: 10.1007/BF02983552. Int J Hematol. 2003. PMID: 14686485 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources